Literature DB >> 27866945

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Debra A Goff1, Ravina Kullar2, Ellie J C Goldstein3, Mark Gilchrist4, Dilip Nathwani5, Allen C Cheng6, Kelly A Cairns7, Kevin Escandón-Vargas8, Maria Virginia Villegas8, Adrian Brink9, Dena van den Bergh10, Marc Mendelson11.   

Abstract

In February, 2016, WHO released a report for the development of national action plans to address the threat of antibiotic resistance, the catastrophic consequences of inaction, and the need for antibiotic stewardship. Antibiotic stewardship combined with infection prevention comprises a collaborative, multidisciplinary approach to optimise use of antibiotics. Efforts to mitigate overuse will be unsustainable without learning and coordinating activities globally. In this Personal View, we provide examples of international collaborations to address optimal prescribing, focusing on five countries that have developed different approaches to antibiotic stewardship-the USA, South Africa, Colombia, Australia, and the UK. Although each country's approach differed, when nurtured, individual efforts can positively affect local and national antimicrobial stewardship programmes. Government advocacy, national guidelines, collaborative research, online training programmes, mentoring programmes, and social media in stewardship all played a role. Personal relationships and willingness to learn from each other's successes and failures continues to foster collaboration. We recommend that antibiotic stewardship models need to evolve from infection specialist-based teams to develop and use cadres of health-care professionals, including pharmacists, nurses, and community health workers, to meet the needs of the global population. We also recommend that all health-care providers who prescribe antibiotics take ownership and understand the societal burden of suboptimal antibiotic use, providing examples of how countries can learn, act globally, and share best antibiotic stewardship practices.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27866945     DOI: 10.1016/S1473-3099(16)30386-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  64 in total

1.  Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.

Authors:  David J Lemon; Matthew K Kay; James K Titus; April A Ford; Wen Chen; Nicholas J Hamlin; Yoon Y Hwang
Journal:  J Microbiol       Date:  2019-05-27       Impact factor: 3.422

2.  Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study.

Authors:  Maher R Khdour; Hussein O Hallak; Mamoon A Aldeyab; Mowaffaq A Nasif; Aliaa M Khalili; Ahamad A Dallashi; Mohammad B Khofash; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

Review 3.  The role of vaccines in preventing bacterial antimicrobial resistance.

Authors:  Kathrin U Jansen; Charles Knirsch; Annaliesa S Anderson
Journal:  Nat Med       Date:  2018-01-09       Impact factor: 53.440

4.  Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI).

Authors:  Cornelius Remschmidt; Sandra Schneider; Elisabeth Meyer; Barbara Schroeren-Boersch; Petra Gastmeier; Frank Schwab
Journal:  Dtsch Arztebl Int       Date:  2017-12-15       Impact factor: 5.594

5.  Evaluation of Antimicrobial Utilization and Concordance with National Guidelines at a Tertiary Hospital in the Southern Highlands Zone of Tanzania.

Authors:  Matthew S Haldeman; Peter Kishimbo; Megan Seddon; Anthony Sangare; Davance Mwasomola; Jeff Hall; Mark Shaffer; Rachel Leclair; Celeste Caulder; Paul Brandon Bookstaver; Anthony Nsojo
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

Review 6.  Prevention of fracture-related infection: a multidisciplinary care package.

Authors:  Willem-Jan Metsemakers; Jolien Onsea; Emilie Neutjens; Ester Steffens; Annette Schuermans; Martin McNally; Stefaan Nijs
Journal:  Int Orthop       Date:  2017-08-22       Impact factor: 3.075

7.  Narrow-Spectrum Antibacterial Agents.

Authors:  Roberta J Melander; Daniel V Zurawski; Christian Melander
Journal:  Medchemcomm       Date:  2017-11-06       Impact factor: 3.597

8.  Mouse model of hematogenous implant-related Staphylococcus aureus biofilm infection reveals therapeutic targets.

Authors:  Yu Wang; Lily I Cheng; David R Helfer; Alyssa G Ashbaugh; Robert J Miller; Alexander J Tzomides; John M Thompson; Roger V Ortines; Andrew S Tsai; Haiyun Liu; Carly A Dillen; Nathan K Archer; Taylor S Cohen; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

9.  The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?

Authors:  Roberta J Melander; Christian Melander
Journal:  ACS Infect Dis       Date:  2017-05-26       Impact factor: 5.084

Review 10.  Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.

Authors:  Andrew F Voter; James L Keck
Journal:  Adv Protein Chem Struct Biol       Date:  2017-08-24       Impact factor: 3.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.